Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial.

待确认 10 由永杰发布于 2025/10/19 12:28:57

DOI:10.1016/S2352-3026(24)00176-5
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/S2352-3026(24)00176-5

Elsevier

Abstract：Background: Some challenges still exist with single-target B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapies due to variable or negative BCMA expression, alth

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

23小时前

亮露

3f4af9ebaca511f0abd634735aa3bc31.pdf

23小时前

Book学术机器人

2025/10/19 12:28:57 未找到该文献，机器人已退出，请等待人工下载

2025/10/19 12:28:57 Book学术AI机器人收到请求，开始寻找文献

2025/10/19 12:28:57 已向机器人发送请求

23小时前

永杰发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Institute of Electrical and Electronics Engineers (IEEE)APCAFlow: All-Pairs Cost Volume Aggregation for Optical Flow Estimation